Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Janssen Files for SC Injection of Darzalex/Vorhyaluronidase Alfa Combo for MM in Japan
Janssen Pharmaceutical has filed for Japan approval of a fixed-dose subcutaneous combination therapy containing its human anti-CD38 monoclonal antibody Darzalex (daratumumab) and vorhyaluronidase alfa for the treatment of multiple myeloma.Darzalex is currently approved in an intravenous infusion formulation. According to…
To read the full story
Related Article
BUSINESS
- Tanabe to Wind Down NeuroDerm, Scrap EU Launch of Parkinson’s Drug
November 19, 2026
- Shionogi Narrows R&D Pipeline to 21 Priority Programs Across 3 Disease Areas
November 19, 2026
- Toho, SDF Hospital Conduct Emergency Drug Supply Drill
November 19, 2026
- Japan Clears Fujirebio’s Blood-Based Aβ42 Test for Alzheimer’s
November 19, 2026
- Sobi Japan to Take Over Orfadin from Astellas in December
November 19, 2026





